Abstract:As one of the members of the kinesin family, the role and potential mechanism of kinesin family member C1 (KIFC1) in the development of liver hepatocellular carcinoma (LIHC), especially in the immune infiltration, have not been fully elucidated. In this study, multiple databases and immunohistochemistry were employed to analyze the role and molecular mechanism including the immune infiltration of KIFC1 in LIHC. Generally, KIFC1 mRNA expression was overexpressed in LIHC tissues than normal tissues, and its protein was also highly expressed in the LIHC. KIFC1 mRNA expression was correlated with tumor grade and TNM staging, which was negatively correlated with overall survival and disease-free survival. Moreover, univariable and multivariate Cox analysis revealed that upregulated KIFC1 mRNA is an independent prognostic factor for LIHC. The KIFC1 promoter methylation level was negatively associated with KIFC1 mRNA expression and advanced stages and grade in LIHC. The different methylation sites of KIFC1 had a different effect on the prognosis of LIHC. Specifically, the KIFC1 mRNA expression level showed intense correlation with tumor immunity, such as tumor-infiltrating immune cells and immune scores as well as multiple immune-related genes. Moreover, KIFC1 co-expressed with some immune checkpoints and related to the responses to immune checkpoint blockade (ICB) and chemotherapies. Significant GO analysis showed that genes correlated with KIFC1 served as catalytic activity, acting on DNA, tubulin binding, histone binding, ATPase activity, and protein serine/threonine kinase activity. KEGG pathway analysis showed that these genes related to KIFC1 are mainly enriched in signal pathways such as cell cycle, spliceosome, pyrimidine metabolism, and RNA transport. Conclusively, KIFC1 was upregulated and displayed a prognostic value in LIHC. Moreover, KIFC1 may be involved in the LIHC progression partially through immune evasion and serve as a predictor of ICB therapies and chemotherapies.

The overexpression of KIFC1 was associated with the proliferation and prognosis of non-small cell lung cancer.

KIFC1, a Novel Potential Prognostic Factor and Therapeutic Target in Hepatocellular Carcinoma.

Prognostic and Clinicopathological Significance of Kinesin Family Member C1 in Various Cancers

Prognostic and clinicopathological significance of kinesin family member C1 in various cancers: A meta-analysis.

High expression of KIFC1 is a poor prognostic biomarker and correlates with TP53 mutation in lung cancer

Increased Kif15 Expression Predicts A Poor Prognosis In Patients With Lung Adenocarcinoma

Identification of KIFC1 as an independent prognostic marker in renal clear cell carcinoma correlates with tumor proliferation and immune infiltration

High expression of Cullin1 indicates poor prognosis for NSCLC patients.

Kinesin family member 2A high expression correlates with advanced tumor stages and worse prognosis in non-small cell lung cancer patients

An Integrative Pan-Cancer Analysis of Kinesin Family Member C1 (KIFC1) in Human Tumors

Prognostic Value and Immunological Role of KIFC1 in Hepatocellular Carcinoma

KIF5B-RET fusions in Chinese patients with non-small cell lung cancer.

Retracted: KIF20A Silence Inhibits the Migration, Invasion and Proliferation of Non‐small Cell Lung Cancer and Regulates the JNK Pathway

KIFC3 promotes the proliferation, migration and invasion of non-small cell lung cancer through the PI3K/AKT signaling pathway

Kinesin Family Member C1 Accelerates Bladder Cancer Cell Proliferation and Induces Epithelial–mesenchymal Transition Via Akt/GSK3β Signaling

Expression of KIF23 and Its Prognostic Role in Non-small Cell Lung Cancer:Analysis Based on the Data-mining of Oncomine

Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer

KIFC3 promotes the progression of non-small cell lung cancer cells through the PI3K/Akt pathway

Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinoma.

Preliminary Study on the Clinical Significance of Kinesin Kif18a in Nonsmall Cell Lung Cancer: an Analysis of 100 Cases.

Overexpression of KIF20A confers malignant phenotype of lung adenocarcinoma by promoting cell proliferation and inhibiting apoptosis